anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Metric

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 79,264
Current window 70,951-70,980
Pages 2,643
Rows per page 30
Component: Metricclear collectionreset all
18 30 60

Component

70,951-70,980 of 79,264

filter-aware
17
The slide uses a narrative of 'fraud' to frame the company's management and reporting practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
19
The slide uses a narrative structure to expose potential accounting opacity and price-driven revenue growth.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
21
The slide uses EMA data to contradict the limited disclosure in the primary trial paper.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
22
The slide uses highlighted quotes to emphasize the lack of data transparency and the high patient drop-off rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
25
The slide uses highly critical, adversarial language ('toxic drug', 'face-planted', 'questionable French lab') to frame the company negatively.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
45
The slide uses a bar chart to visualize payment data from CMS OpenPayments to support a narrative of questionable marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
54
The slide uses a bar chart to compare reporting rates per million daily doses, with specific focus on drugs withdrawn from the market due to cardiac safety concerns.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
55
The slide uses a calculation of daily doses sold based on revenue and price to derive a rate, then compares this against historical data from a Lancet study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
61
The slide uses a combination of narrative text and a supporting data table to argue that certain structural features are predictive of drug safety risks.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
105
The slide uses a 'quote-and-critique' structure to expose potential data manipulation in clinical reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
107
The slide uses an FDA review document to highlight a safety risk (QTc prolongation) that the company allegedly downplays.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
118
The slide uses a 'black box' argument to challenge the validity of the sponsor's pharmacokinetic model.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
123
The slide uses a red box to highlight a specific data point (40mg dose) in a table to support the argument of inconsistent reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
124
The slide uses a specific FDA review document (NDA 211150) to challenge official plasma level claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
126
The slide uses a table to expose data inconsistencies and safety risks, framing the variability as a 'red flag' regarding the drug's safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
128
The slide uses a direct quote from an FDA clinical review to contradict the company's safety claims, supported by a table of clinical data.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
119
The slide uses a grouped bar chart to highlight performance inconsistency across five separate runs.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Loop · Iceberg1 hit
120
The slide uses a direct comparison to Theranos to frame the company's operational issues as potentially fraudulent.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Loop · Iceberg1 hit
122
The slide uses a direct quote from an internal paper to contradict the company's public narrative on scalability.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
136
The slide uses direct quotes from interviews to contrast with a specific IonQ press release.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
137
The slide uses direct quotes to frame IonQ's technology as inferior to its competitor, Honeywell.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
141
The slide uses a screenshot of an investor presentation to contrast public claims with the company's own internal forecasts.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
143
The slide uses a snippet from a 10Q filing to contrast narrative with financial reality.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
145
Uses highlighted text to draw attention to the specific evidence of customer concentration.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
147
The slide uses a 'round-tripping' argument, contrasting revenue received from related parties against expenses paid to them.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
148
The slide uses a table to derive Q4 figures from annual and Q3 year-to-date data, highlighting a spike in related-party revenue dependency.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
149
The slide uses a 'before-after' or 'contradiction' framing to highlight the discrepancy between actual revenue and projected bookings.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
150
The slide uses a narrative structure to cast doubt on the legitimacy of the company's announcements.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated1 hit
154
The slide uses red boxes to highlight specific line items in a financial table to draw attention to the alleged accounting irregularity.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
155
The slide uses a combination of narrative accusation and direct quotes from earnings materials to build a case of financial misrepresentation.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit